← Back to Search

Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention

N/A
Waitlist Available
Led By Lisa A. Marsch, Ph.D.
Research Sponsored by National Development and Research Institutes, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This study will evaluate the comparative effectiveness and cost-effectiveness of a customized, interactive web-based HIV, sexually transmitted infections (STI) and hepatitis prevention intervention as compared to a traditional, educator-delivered prevention intervention. Both interventions will be offered to youth enrolled in outpatient, community-based substance abuse treatment at our collaborating treatment facilities. Outcomes to be measured include accurate HIV/disease prevention knowledge, intentions to engage in safer sex, actual HIV risk behavior, attitudes toward safer sex and self-reported substance use. The web-delivered intervention under evaluation has the potential to deliver evidence-based content at low cost without increasing demands on treatment staff time or training needs.

Eligible Conditions
  • Human Immunodeficiency Virus Infection
  • Hepatitis
  • Sexually Transmitted Diseases

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HIV risk behavior
behavioral intentions
Secondary study objectives
self-reported substance use
skills acquisition

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Web-based PreventionExperimental Treatment1 Intervention
self-directed, interactive \& customized web-based HIV \& disease prevention education
Group II: Traditional PreventionActive Control1 Intervention
educator-delivered, small-group HIV \& disease prevention education

Find a Location

Who is running the clinical trial?

National Development and Research Institutes, Inc.Lead Sponsor
37 Previous Clinical Trials
12,835 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,607 Previous Clinical Trials
3,329,695 Total Patients Enrolled
Honoria M. Guarino, Ph.D.Study DirectorNational Development and Research Institutes, Inc.
Lisa A. Marsch, Ph.D.Principal InvestigatorNational Development and Research Institutes, Inc.
2 Previous Clinical Trials
329 Total Patients Enrolled
~8 spots leftby Jan 2026